Health plans sold on the Obamacare exchanges are still losing money, but most U.S. health insurers are on track for continued strong earnings in 2017 in other segments of their markets.
That was the message from S&P Global Ratings analysts, who spoke on a webinar recently.
Seven of the nine public managed care companies—UnitedHealth Group Inc., Aetna Inc., Humana Inc., Anthem Inc., Cigna Corp., Centene Corp. and WellCare Health Plans Inc.—raised their earnings guidance for 2017, associate director James Sung said.
Following a strong second quarter, “They’re on pace for a very strong earnings year; so strong momentum actually the last few years,” Sung said.
Key to the success of the health insurers is their large group commercial business, but the companies have also benefited from growth in managing plans for the large government health-care programs Medicare and Medicaid.
The importance of government health-care programs is highlighted by the fact that, if administrative fees insurers earn for operating self-insured group plans for companies are excluded, 60 percent of the premiums health insurers collect are linked to Medicare, Medicaid, the Affordable Care Act exchanges and the Federal Employees Health Benefits Program, S&P director Deep Banerjee said.
The individual market, which is the smallest part of the health insurance market, is the most volatile segment, but that is linked to the recent changes made in that market by the ACA, which was enacted in 2010, Banerjee said.
State Blue Cross Blue Shield plans, the largest plans in the ACA exchanges, are likely to continue to stay in the exchanges because the local markets are an important part of their business, Banerjee said.
But companies operating in the exchanges won’t likely show profits on average until 2018, Banerjee said.
But Aug. 11, Anthem Inc., a major Blue Cross Blue Shield company, announced further withdrawals from the 2018 ACA exchanges. The company said it wouldn’t participate in the individual exchange in Virginia “due to a shrinking and deteriorating individual market, as well as continual changes and uncertainty in federal operations, rules and guidance, including cost sharing reduction subsidies and the restoration of taxes on fully insured coverage.”
Read my full article here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)